title: Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
abstract: Morbidity and mortality associated with tobacco smoking constitutes a significant burden on healthcare budgets all over the world. Therefore, promoting smoking cessation is an important goal of health professionals and policy makers throughout the world. Nicotine is a major psychoactive component in tobacco that is largely responsible for the widespread addiction to tobacco. A majority of the currently available FDA-approved smoking cessation medications act via neuronal nicotinic receptors. These medications are effective in approximately half of all the smokers, who want to quit and relapse among abstinent smokers continues to be high. In addition to relapse among abstinent smokers, unpleasant effects associated with nicotine withdrawal are a major motivational factor in continued tobacco smoking. Over the last two decades, animal studies have helped in identifying several neural substrates that are involved in nicotine-dependent behaviors including those associated with nicotine withdrawal and relapse to tobacco smoking. In this review, first the role of specific brain regions/circuits that are involved in nicotine dependence will be discussed. Next, the review will describe the role of specific nicotinic receptor subunits in nicotine dependence. Finally, the review will discuss the role of classical neurotransmitters (dopamine, serotonin, noradrenaline, glutamate, and γ-aminobutyric acid) as well as endogenous opioid and endocannabinoid signaling in nicotine dependence. The nicotinic and nonnicotinic neural substrates involved in nicotine-dependent behaviors can serve as possible targets for future smoking cessation medications.
authors.affiliation: Department of Biomedical and Pharmaceutical Sciences, The Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA. Electronic address: m-dsouza@onu.edu.
authors.forename: Manoranjan S
authors.initials: MS
authors.lastname: D'Souza
mesh_terms: D000818:Animals; D016739:Behavior, Addictive / Q000523:psychology*; D001921:Brain / Q000503:physiopathology*; D006801:Humans; D009538:Nicotine / Q000009:adverse effects*; D011978:Receptors, Nicotinic / Q000187:drug effects; D016540:Smoking Cessation / Q000523:psychology*; D014029:Tobacco Use Disorder / Q000523:psychology*
chemical_list: D011978:Receptors, Nicotinic; D009538:Nicotine
keywords: Endocannabinoids; GABA; Glutamate; Habenula; Interpeduncular nucleus; Nicotine withdrawal; Nucleus accumbens; Opioids; Reinstatement; Serotonin